Filing Details
- Accession Number:
- 0001095449-21-000025
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-05 18:57:14
- Reporting Period:
- 2021-03-02
- Accepted Time:
- 2021-03-05 18:57:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1008586 | Streamline Health Solutions Inc. | STRM | Services-Computer Integrated Systems Design (7373) | 311455414 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1395296 | Tamarack Global Healthcare Fund, L.p. | 5050 Avenida Encinas Suite 360 Carlsbad CA 92008 | No | No | Yes | No | |
1537996 | Tamarack Capital Management, Llc | 5050 Avenida Encinas Suite 360 Carlsbad CA 92008 | No | No | Yes | No | |
1612092 | Tamarack Global Healthcare Fund Qp, L.p. | 5050 Avenida Encinas Suite 360 Carlsbad CA 92008 | No | No | No | Yes | |
1661462 | Tamarack Advisers, Lp | 5050 Avenida Encinas Suite 360 Carlsbad CA 92008 | No | No | Yes | No | |
1667225 | Tamarack Capital Gp, Llc | 5050 Avenida Encinas Suite 360 Carlsbad CA 92008 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Acquisiton | 2021-03-02 | 625,000 | $1.60 | 4,223,334 | No | 4 | A | Direct | |
Common Stock, $0.01 Par Value | Acquisiton | 2021-03-02 | 625,000 | $1.60 | 4,930,882 | No | 4 | P | Indirect | See footnote 2 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | P | Indirect | See footnote 2 |
Footnotes
- The acquired securities are reported on 2 lines because the acquisition results in different ownership positions for the reporting parties.
- The reported securities represent 4,223,334 shares held directly by Tamarack Global Healthcare Fund, L.P. ("Fund 1") and 707,548 shares held directly by Tamarack Global Healthcare Fund QP, L.P. ("Fund 2"). Tamarack Capital Management, LLC is the general partner of Fund 1 and Fund 2 and Tamarack Advisers, LP is the investment adviser to Fund 1 and Fund 2. Tamarack Capital GP, LLC is the sole partner of Tamarack Advisers, LP. Tamarack Capital Management, LLC, Tamarack Advisers, LP, and Tamarack Capital GP, LLC may be deemed indirect beneficial owners of the shares held by Fund 1 and Fund 2 for purposes of Section 13(d) of the Securities Exchange Act of 1934 (the "Act").
- Tamarack Capital Management, LLC, Tamarack Advisers, LP, and Tamarack Capital GP, LLC disclaim beneficial ownership of any of the shares held by Fund 1 and Fund 2 for the purpose of determining whether they are subject to Section 16 of the Act, however, in reliance on Rule 16a-1(a)(1)(v) and (vii) under the Act. To the extent that they might be deemed subject to Section 16, they disclaim beneficial ownership of securities held by the Fund 1 and Fund 2 for purposes of Rule 16a-1(a)(2), except to the extent of their pecuniary interest therein, if any.